TFX Earnings

TFX reported its FY2025Q4 earnings on 2026-02-24, showcasing a revenue of 0.00 against an estimate of 941.00M, resulting in a 0% surprise. The EPS was 0, surpassing the expected 3.79 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following TFX's FY2025Q4 earnings announcement on 2026-02-24, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, TFX's stock price tends to shift by an average of +5.39% in the 10 days leading up to earnings and +0.02% in the 10 days following, providing insight into potential market.

For 2025/Q4, analysts estimate TFX’s annual revenue to reach 934.00M, while the EPS is projected at 4.00. These estimates reflect recent revisions, with revenue estimates revised Revenue Revise Downward by -0.45% and EPS estimates Revise Downward by -1.92% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between TFX's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were Revise Downward by -0.45%, while EPS estimates moved Revise Downward by -1.92% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, TFX's stock price typically moves by +5.39% in the 10 days before its earnings and +0.02% in the 10 days after. For the upcoming 2025/Q4 earnings, analysts expect an EPS of 4.00 and revenue of 934.00M.

The earnings call highlights several positive factors: increased revenue growth guidance, improved adjusted gross margins, and strong performance in the Vascular Intervention business. The Q&A session further supports this with positive insights on market share growth and successful integration of acquisitions. Although cash flow from operations decreased, the overall financial outlook and strategic plans, including a focus on maximizing shareholder value through a potential sale, suggest a positive sentiment. The upward revision of guidance and strong market performance indicate a likely positive stock price movement in the short term.